Healthcare Under Masisi: Expanding Access and Strengthening Rural Services
Healthcare policy during Mokgweetsi Masisi's presidency from 2018 to 2024 unfolded against the backdrop of a global pandemic, longstanding rural access disparities, and the fiscal demands of sustaining one of Africa's most comprehensive HIV treatment programmes. Masisi's administration navigated these pressures while continuing maternal health initiatives, vaccination campaigns, and facility expansion programmes inherited from and built upon decades of BDP governance in the health sector.
Botswana's health system occupies an unusual position in regional comparison. The country achieves relatively strong outcomes on indicators such as life expectancy and antiretroviral coverage, yet faces persistent shortages of specialists, uneven distribution of facilities, and the administrative complexity of coordinating services across vast, sparsely populated districts. Masisi's health policy record reflects both emergency response capabilities and the structural limits of incremental reform.
COVID-19 Response
The COVID-19 pandemic dominated health policy during much of Masisi's term. The government implemented movement restrictions, border controls, and social distancing measures during 2020 and 2021, balancing public health objectives against economic disruption in a tourism-dependent economy. Botswana participated in global vaccine procurement through COVAX and bilateral agreements, rolling out vaccination campaigns that initially prioritised health workers, the elderly, and those with comorbidities before expanding to the general adult population.
Assessment of the COVID response is mixed. Supporters credit the administration with preventing health system collapse and achieving reasonable vaccination coverage relative to regional peers. Critics highlight economic hardship caused by lockdowns, concerns about procurement transparency, and delays in reaching rural communities with vaccine doses. Parliamentary committees and civil society organisations raised questions about emergency expenditure that the administration defended as necessary under crisis conditions.
"Pandemic response tests not only medical capacity but the trust between citizens and institutions charged with protecting public health." — Epidemiologists studying Southern Africa's COVID experience frequently emphasise this dual dimension.
Maternal Health and Rural Access
Maternal health programmes continued during Masisi's presidency, building on Botswana's progress toward Millennium Development Goal targets in the preceding decade. Initiatives included skilled birth attendance promotion, prenatal care outreach, and facility upgrades in district hospitals serving obstetric emergencies. Rural access remained a priority challenge: pregnant women in remote areas sometimes travelled long distances to reach equipped facilities, and ambulance services faced coverage gaps.
The administration supported construction and refurbishment of health posts and clinics, particularly in Central District, Kgalagadi, and other areas with low population density. Telemedicine pilot projects and mobile clinic deployments were explored as supplements to fixed infrastructure, though scale remained limited. Health economists note that rural access improvements require sustained personnel recruitment — doctors and nurses willing to serve in remote postings — not infrastructure alone.
Facility Expansion and the ARV Programme
Facility expansion during Masisi's term included new primary health centres and upgrades to existing district hospitals. Budget allocations for health generally maintained or modestly increased as a share of total government spending, though COVID-related costs competed with routine programme funding. The administration publicly committed to continuing Botswana's free antiretroviral therapy programme, which serves hundreds of thousands of citizens and residents living with HIV.
- COVID-19 vaccination campaigns and public health restrictions during 2020–2021
- Continued maternal health outreach and skilled birth attendance programmes
- Health post construction and district hospital refurbishment in rural areas
- Sustained free antiretroviral treatment under the national HIV programme
- Telemedicine and mobile clinic pilot projects in underserved districts
The ARV programme represents one of Botswana's most significant public health achievements. Maintaining drug supply chains, laboratory monitoring capacity, and adherence support during pandemic disruptions required administrative coordination across the Ministry of Health, pharmaceutical suppliers, and international partners. Masisi's government preserved programme continuity, an outcome that health advocates acknowledge even when criticising other aspects of his health record.
Vaccination Campaigns Beyond COVID
Routine immunisation programmes for childhood diseases continued alongside COVID vaccination efforts. The administration participated in regional polio surveillance and maintained cold-chain infrastructure necessary for vaccine storage in hot climates. Outreach campaigns targeted communities with historically lower immunisation rates, though data on coverage variation across districts suggests uneven reach.
Assessment and Continuing Challenges
Masisi's health policy legacy combines effective crisis management on ARV continuity and reasonable pandemic response with unfinished work on rural access, mental health services, and specialist capacity. Non-communicable diseases — diabetes, hypertension, cancer — increased as priorities during his term, reflecting epidemiological transition in a country where infectious disease programmes had dominated health planning for decades.
Opposition parties, including the UDC coalition that defeated the BDP in 2024, campaigned on promises to accelerate rural health infrastructure and expand mental health services. Whether Masisi's incremental approach adequately addressed public expectations became a political question as much as a clinical one. Neutral assessment suggests a record of stability and continuity in core programmes, paired with insufficient breakthrough on structural access inequalities that require generational investment rather than single-term solutions.
